Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00504634 · ClinicalTrials.gov registry record · Phase 2

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

A Phase 2 study of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Phase 2
Development phase
8
Enrollment target
1
Study location

NCT00504634: Completed Phase 2 study of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.

NCT00504634 is a Phase 2 study of Multiple Myeloma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 8 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00504634, a Phase 2 study of Multiple Myeloma, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Primary Objective: 1\. To determine the antimyeloma effect of bortezomib after allogeneic transplantation for patients with multiple myeloma. Secondary Objective 1\. To determine the toxicity profile of bortezomib in patients with multiple myeloma undergoing allogeneic progenitor cell transplantation.

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG Bortezomib

Study Locations (1)

Texas

  • UT MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2004-01
Est. Completion 2010-05
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00504634

The ClinicalTrials.gov registry entry for NCT00504634 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which Bortezomib is the first listed.

NCT00504634 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00504634 about?

NCT00504634 is a clinical study titled "Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma". Primary Objective: 1\. To determine the antimyeloma effect of bortezomib after allogeneic transplantation for patients with multiple myeloma. Secondary Objective 1\. To determine the toxicity profile of bortezomib in patients with multiple myeloma undergoing allogeneic progenitor cell transplanta...

What is the current status of trial NCT00504634?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2004-01. Estimated completion is 2010-05.

What conditions does trial NCT00504634 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT00504634?

The interventions under investigation include: Bortezomib (DRUG).

Who is sponsoring clinical trial NCT00504634?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00504634 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.